Robert A. Byrne
Robert A. Byrne
Cardiovascular Research Institute (CVRI) Dublin, Mater Private Hospital, Dublin, Ireland; School of
materprivate.ie üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
2018 ESC/EACTS Guidelines on myocardial revascularization
FJ Neumann, M Sousa-Uva, A Ahlsson, F Alfonso, AP Banning, ...
European heart journal 40 (2), 87-165, 2019
28042019
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ...
European journal of cardio-thoracic surgery 53 (1), 34-78, 2018
17032018
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
ML von Brühl, K Stark, A Steinhart, S Chandraratne, I Konrad, M Lorenz, ...
Journal of Experimental Medicine 209 (4), 819-835, 2012
11872012
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of …
M Seyfarth, D Sibbing, I Bauer, G Fröhlich, L Bott-Flügel, R Byrne, ...
Journal of the American College of Cardiology 52 (19), 1584-1588, 2008
8202008
5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction
G Ndrepepa, K Tiroch, M Fusaro, D Keta, M Seyfarth, RA Byrne, J Pache, ...
Journal of the American College of Cardiology 55 (21), 2383-2389, 2010
4312010
Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease …
PS Douglas, G Pontone, MA Hlatky, MR Patel, BL Norgaard, RA Byrne, ...
European heart journal 36 (47), 3359-3367, 2015
4042015
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of …
GG Stefanini, RA Byrne, PW Serruys, A de Waha, B Meier, S Massberg, ...
European heart journal 33 (10), 1214-1222, 2012
3932012
Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial
KA Fiedler, M Maeng, J Mehilli, S Schulz-Schüpke, RA Byrne, D Sibbing, ...
Journal of the American College of Cardiology 65 (16), 1619-1629, 2015
3852015
Current treatment of in-stent restenosis
F Alfonso, RA Byrne, F Rivero, A Kastrati
Journal of the American College of Cardiology 63 (24), 2659-2673, 2014
3802014
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
RA Byrne, M Joner, A Kastrati
European heart journal 36 (47), 3320-3331, 2015
3772015
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute …
JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ...
European heart journal 42 (14), 1289-1367, 2021
374*2021
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention
A Kastrati, FJ Neumann, J Mehilli, RA Byrne, R Iijima, HJ Büttner, ...
New England Journal of Medicine 359 (7), 688-696, 2008
3592008
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography
S Cassese, RA Byrne, T Tada, S Pinieck, M Joner, T Ibrahim, LA King, ...
Heart 100 (2), 153-159, 2014
3572014
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials
S Cassese, RA Byrne, G Ndrepepa, S Kufner, J Wiebe, J Repp, ...
The Lancet 387 (10018), 537-544, 2016
3382016
Abciximab and heparin versus bivalirudin for non–ST-elevation myocardial infarction
A Kastrati, FJ Neumann, S Schulz, S Massberg, RA Byrne, M Ferenc, ...
New England Journal of Medicine 365 (21), 1980-1989, 2011
3292011
ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary …
M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ...
Eur Heart J 39 (3), 213-260, 2018
3242018
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a …
RA Byrne, FJ Neumann, J Mehilli, S Pinieck, B Wolff, K Tiroch, S Schulz, ...
The Lancet 381 (9865), 461-467, 2013
3102013
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
F Otsuka, RA Byrne, K Yahagi, H Mori, E Ladich, DR Fowler, R Kutys, ...
European heart journal 36 (32), 2147-2159, 2015
3092015
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
S Schulz-Schüpke, RA Byrne, JM Ten Berg, FJ Neumann, Y Han, ...
European heart journal 36 (20), 1252-1263, 2015
3072015
2018 ESC/EACTS Guidelines on myocardial revascularization
M Sousa-Uva, FJ Neumann, A Ahlsson, F Alfonso, AP Banning, ...
European journal of cardio-thoracic surgery 55 (1), 4-90, 2019
3012019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20